liferation followed by progressive sclerosis [4] , and mice transgenic for growth hormone ultimately develop severe progressive mesangial sclerosis. They show a fiveIn the adult organism, normally quiescent cells exhibit fold increase in the 3 H-thymidine-labeling index of gloincreased replication rates during tumorigenesis or in merular cells. Interestingly, the labeling index remained the tissue repair processes following injury. In the renal high at late time points in densely sclerotic glomeruli glomerulus, very different types of injury are able to
in the control of MC proliferation appears to play an source of injury, an imbalance in the control of mesangial cell early and crucial role in the pathogenesis of progressive proliferation appears to play a direct role in the degree of glomerular injury and glomerulosclerosis. In experimenprogressive renal injury and glomerulosclerosis. Some of the tal models of nephritis, MC proliferation frequently preregulatory mechanisms include specific soluble or non-soluble cedes and is linked to the increase of extracellular matrix extracellular factors and a complex array of receptor-mediated signals that control the progression of the cell cycle or cell (ECM) in the mesangium and glomerulosclerosis [2, 3] .
death. Understanding these regulatory processes could lead to For example, mice transgenic for the SV40 T antigen, novel therapeutic strategies to alleviate or arrest proliferative which has growth-promoting functions, develop MC proglomerular disease.
liferation followed by progressive sclerosis [4] , and mice transgenic for growth hormone ultimately develop severe progressive mesangial sclerosis. They show a fiveIn the adult organism, normally quiescent cells exhibit fold increase in the 3 H-thymidine-labeling index of gloincreased replication rates during tumorigenesis or in merular cells. Interestingly, the labeling index remained the tissue repair processes following injury. In the renal high at late time points in densely sclerotic glomeruli glomerulus, very different types of injury are able to [2] , indicating that increased MC turnover can be a siginduce local inflammatory reactions involving resident nificant feature associated with sclerosis, both at the onglomerular cells. Lesions may be immune mediated, inset and in later stages. fectious, toxic, mechanical, or of other etiologies. A Moreover, measures that reduce cell proliferation in prominent histopathological feature of many human and glomerular disease models, such as treatment with hepaexperimental glomerular inflammatory diseases is cellurin [5] , low-protein diet [6] , or neutralizing antibodies to lar hyperplasia in the mesangium, which is caused by platelet-derived growth factor (PDGF) [7] , have been proliferation of mesangial cells (MCs) and an influx of shown to reduce ECM expansion and sclerotic changes. leukocytes (Fig. 1) . In this article we discuss the pathoFurther evidence for the role of uncontrolled MC prolifphysiological relevance of increased MC proliferation in eration in the pathogenesis of glomerulosclerosis was the context of glomerular disease progression and review provided by work of Pippin et al, who studied the effects some of the extracellular factors and molecular mechaof the pharmacological cdk2 inhibitor roscovitine on disnisms controlling MC growth.
ease progression in mesangioproliferative anti-Thy1.1 nephritis of the rat [8] . The application of the purine
RELEVANCE OF INCREASED MESANGIAL
analogue roscovitine resulted in a significant reduction of CELL PROLIFERATION MC proliferation and glomerular cellularity in nephritic Pathogenetic linkage of mesangial cell hyperplasia and animals. Notably, the decrease of MC replication was glomerulosclerosis associated with a marked reduction of mesangial ECM Because proliferation of MCs in the normal adult kidaccumulation and less deposition of collagen type IV, ney is tightly regulated with a growth rate of less than laminin, and fibronectin [8] . 1% [1] , quiescent MCs can be assumed to interact with Reconstitutive mesangial cell proliferation in no or few mitogens and/or to be protected by either glomerular repair down-regulation of receptors or the presence of growthinhibitory factors maintaining the low proliferative activPersistent MC hyperplasia caused by repetitive or conity. Regardless of the injurious mechanism, an imbalance tinuous glomerular injury is thought to precede and lead to irreversible glomerular scarring and the loss of renal function. However, like in regular wound healing, the glomerular reconstitution and renal tissue repair. Eviloss of MCs, such as anti-Thy1.1 nephritis [9] or Habu toxin glomerulopathy [10] , exhibit marked proliferation dence for this concept comes from observations in several types of human glomerular diseases, for example, of MCs leading to transient MC hyperplasia and matrix accumulation. If no repetitive insult to the mesangium is poststreptococcal glomerulonephritis and some forms of lupus nephritis. These diseases show marked expansion added in these animals, both diseases show spontaneous repair of the glomerular tufts within a few weeks, indicatof the mesangium because of MC hyperplasia, which may subsequently resolve completely once the inflammatory ing that early and pronounced MC replication may indeed be part of the physiological reconstitutive response cause has subsided. In addition, experimental animal models of mesangiolytic injury characterized by a rapid of glomeruli to injury, such as mesangiolysis. Thus, thera- peutical manipulations aiming to block MC mitogenesis can distinguish between "reconstitutive" proliferation of could represent a double-edged sword. Although the the remaining MCs after mesangiolysis from "nonreavailable evidence suggests that control of overshooting constitutive" or "orthotopic" MC replication in response MC replication is beneficial in reducing ECM accumulato activation of intact MCs, for example, by soluble tion, interference with reconstitutive proliferation of growth factors. However, it should be noted that in vivo MCs could conceivably lead to incomplete cellular rethese histological features may occur simultaneously, population of the glomerular tuft and defective repair.
even within the same glomerulus. Currently, the methodClearly, more precise markers than MC hyperplasia are ology is insufficient to discern the nature of the proliferaneeded to better characterize the dynamic nature of MC tive processes in glomerulonephritis. This problem is proliferation and its regulators in proliferative glomeruaggravated in the evaluation of human glomerular dislonephritis. This would also allow a more rational evaluaeases because of the fact that a regular kidney biopsy tion of the effects of growth-inhibitory manipulations in specimen yields but a limited number of tissue sections proliferative glomerular diseases following the loss of with rather few glomeruli. Currently, these limitations MCs and in chronic-progressive disease stages. Figure 2 prevent thorough and meaningful studies of glomerular schematically depicts two types of increased MC proliferation in response to glomerular injury. Conceptually, one cell turnover in patients.
Apoptosis: A clearing mechanism balancing mesangial in this model is associated with significant and transient increases of cyclin A and cdk2 protein [20] . Moreover, cell hyperplasia the increase of cdk2 protein expression in the course of When recovery of mesangioproliferative disease ocnephritis correlated with an increase of cdk2 activity, as curs, how is the resolution of hypercellularity achieved? measured by histone H1 kinase assay in isolated glomerTheoretically, resolution would require the reduction of uli. In normal rat glomeruli, the expression of the CKI the baseline regeneration or proliferation rate and/or p27 Kip1 was high, whereas the levels of p21 Waf-1 were low. increased removal or death of MCs. Recent research has
The onset of MC proliferation in the anti-Thy1.1 model examined cell apoptosis, a process that uses a controlled was associated with a reduction of p27 Kip1 levels. The program to achieve cell death. In glomeruli, apoptotic resolution of MC proliferation was associated with a bodies can be found in renal biopsies from patients with return to baseline levels for p27 Kip1 , whereas the expresproliferative glomerulonephritis [11] . Baker et al and sion for p21 Waf-1 further increased and remained elevated Shimizu et al demonstrated that MC apoptosis is a cell following the resolution of proliferation [20] . The releclearance mechanism counterbalancing MC division in vance of the sustained p21 Waf-1 was not fully explained, self-limited anti-Thy1.1 glomerulonephritis, thereby conbut one could speculate that p21 Waf-1 has a functional tributing to the resolution of glomerular hypercellularity role in the long-term resolution of mesangioproliferative caused by experimentally induced MC proliferation in disease. Currently, however, this interpretation is unrats [12, 13] . In these experiments, mitotic and apoptotic proven. cells were detected in the same glomerulus, suggesting Indeed, recent data have shown that p21 Waf-1 has diverthat both processes can occur simultaneously. Although gent functions. The CKI p21 Waf-1 can act as an assembly these studies imply a beneficial role of apoptosis as a factor of cdk4/cyclin D complexes or as an inhibitor of mechanism leading to the reduction of MC hyperplasia CDK/cyclin complexes [16, 21] . We have recently examand thereby contributing to the resolution of glomerular ined how soluble regulators of MC growth affect p21
Waf-1 disease, other data indicate that excessive apoptosis can expression in cultured MCs. We found that PDGF causes be harmful, leading to glomerular hypocellularity [14] . a marked increase of p21 Waf-1 protein in MCs [22] . The Again, these observations reflect the fact that glomerular induction of p21 Waf-1 protein by PDGF was also reported MC numbers at any given stage during glomerular disin p53-deficient as well as in normal mouse fibroblasts, ease are determined by the rates of cell proliferation and supporting the interpretation of p53-independent uploss. Clearly, homeostatic reconstitution of the glomeruregulation of p21 Waf-1 by PDGF [23] . In other cell types, lus depends on a regulated balance between these two the growth-inhibitory cytokine transforming growth facprocesses. The precise mechanisms controlling the glotor-␤1 (TGF-␤1) was found to enhance p21 Waf-1 expresmerular cell turnover and net cell number in health and sion by p53-independent mechanisms [24] . However, our disease are currently incompletely understood.
experiments showed that in cultured rat MCs, TGF-␤1 led to a slight reduction of the p21 Waf-1 expression, which MOLECULAR CONTROL OF MESANGIAL was induced by PDGF [22] , whereas it strongly stimu-CELL CYCLE PROGRESSION lated p27 Kip1 . These divergent findings indicate that the nature of TGF-␤1-mediated effects on cell cycle regulaThe division cycle of eukaryotic cells is controlled by a series of checkpoints and transitions in which temporal tory proteins differs considerably between cell types. In our studies, we observed that increased nuclear order is imposed by cyclin-dependent kinases (CDKs), acting in concert with their regulatory subunits, the abundance of cyclin D1 protein in MCs precedes the peak of MC hypercellularity in anti-Thy1.1 glomerulonecyclins (Fig. 3) [15] . Cyclin kinase inhibitors (CKIs), such as p21
Waf-1 , p27 Kip1 , and members of the INK4 family of phritis ( Fig. 1) , suggesting its involvement in the development of mesangioproliferative disease [22] . To further CDK inhibitors, negatively regulate the cell cycle by inhibiting the formation or activation of cyclin-CDK examine the relevance of the in vivo finding of enhanced cyclin D1 expression for MC hyperplasia, we studied the complexes [16] . In the past few years, considerable advances have been made in this field of research, and effects of soluble regulators of MC growth on cyclin D1 expression in vitro. In growth-arrested rat MCs in nephrologists are applying this knowledge to elucidate the molecular control of cell cycle progression of renal culture, mitogenic stimulation with serum or PDGF led to a rapid increase of cyclin D1 protein expression. cells, including MCs. New findings on molecular mechanisms of cell cycle control were presented at this sympo-TGF-␤1 inhibited PDGF-related induction of cyclin D1 protein. Because cyclin D1 is a key regulator of early sium and are the subject of recent reviews [16] [17] [18] [19] .
The rat anti-Thy1.1 model of mesangioproliferative G1-phase progression and adenovirus-mediated overexpression of cyclin D1 in MCs increased MC mitogenesis glomerulonephritis has been used to study the in vivo expression of cell cycle regulators in glomerular cells.
[25], we examined whether the reduction of cyclin D1 protein abundance by transfection of antisense oligonuShankland et al showed that the onset of MC replication Fig. 3 . Schematic diagram of the signaling pathway that mediates cell cycle progression through the G1 into the S phase. Cell cycle progression is controlled by cyclin-dependent kinases (CDK) and their regulatory subunits, the cyclins. Nuclear kinase inhibitors (for example, p15, p16, p21, and p27) modulate the enzymatic activity of cyclin/CDK complexes. External (for example, TGF-␤, PDGF, collagen I) or internal regulators (for example, p53) influence the activity and/or expression of these inhibitors. The transcription factor E2F is repressed by its binding to the underphosphorylated form of the retinoblastoma gene product (pRb). Phosphorylation of pRb activates E2F, which induces the transcription of target genes essential for G1 and S phase progression. The abortion of G1 phase progression may result in apoptosis or allow for DNA repair. The restriction point (R) in the late G1 phase is where cells commit to completing the cell cycle.
cleotides (ODNs) is sufficient to inhibit cdk4 kinase acgies aiming to reduce cyclin D1 expression, for example, by transfer of antisense ODNs or by specific cyclin antagtivity and MC proliferation. Several studies successfully employed transfection of antisense ODNs to examine onists, might represent an effective means to inhibit MC proliferation in vivo. the roles of MC growth regulators and to block MC replication. In cultured MCs, proliferation could be inOther studies investigated whether or not MC replication is reduced by suppressing the activity of transcriphibited by using antisense ODNs against the early growth response gene Egr-1 [26] or other cell cycle-associated tion factor E2F. E2F controls the expression of several genes involved in cell cycle progression, including c-myc, proteins such as PCNA or Ki-67 [27]. We observed that antisense ODNs against cyclin D1 reduced the serumc-myb, proliferating cell nuclear antigen (PCNA), and cdk2 kinase [19] . In order to inhibit E2F, decoy ODNs or PDGF-induced protein expression of cyclin D1 to 48% or 10% of control levels, respectively [22] . These that contained the consensus E2F binding site sequence as a competitive inhibitor were transfected. Transfection inhibitory effects correlated with diminished cdk4 activity. Subsequently, the MC proliferation caused by serum of E2F Transforming growth factor-␤1 has also been reported to cause hypertrophy of renal cells, including renal epithelial cells [41] and MCs [42, 43] Kip1 protein abundance in glomeruli of diabetic reports exist on promitogenic factors and signaling pathanimals, which apparently was because of hyperglycemia ways in MCs, less is known about antimitogenic mecha- [46] . With regard to MC growth control in glomerular nisms that are able to block MC proliferation and might disease, the available data indicate that TGF-␤ not only be involved in the maintenance of MC quiescence in the mediates the deposition of ECM but also functions as normal kidney and/or in the resolution of mesangioprolia potent autocrine inhibitor of G1-phase progression. ferative disease. TGF-␤ is a potent endogenous growthDependent on the type and phase of glomerular disease, inhibitory factor with the capacity to counterbalance MC the effects of TGF-␤ could therefore contribute to the mitogenesis; it is secreted by MCs and can act in an resolution of hypercellular disease or lead to MC hyperautocrine fashion [32] . The ECM represents a very heterogenous source of molecular information that profoundly regulates cell bestrated that mesangial overexpression of active TGF-␤1 by the use of MCs as a vector for gene delivery to the havior. Changes in the quantity and composition of the mesangial ECM can directly affect MC biology; in turn, renal glomerulus reduced increased glomerular mitogenesis in anti-Thy1.1 nephritis, implying that TGF-␤1 acts changes in the MC activation status may result in altered ECM synthesis. Under normal conditions, mesangial as a suppressor of glomerular inflammation [36] .
We have investigated nuclear regulatory events in-ECM compounds are synthesized and degraded in a balanced manner because the integrity of glomerular matriduced by TGF-␤1 in MCs [35] . TGF-␤1 abrogated mitogenesis of cultured MCs stimulated by PDGF, epidermal ces is strictly maintained throughout adult life. However, the loss of coordinated regulation with increase in mesgrowth factor (EGF), serotonin, endothelin-1, or basic fibroblast growth factor (bFGF). By FACS analysis, we angial ECM deposition occurs in the development of glomerulosclerosis, a common feature of many forms of observed that the incubation of cultured MCs with TGF-␤1 blocks the progression of the MC cycle in the G1 chronic inflammatory glomerular disease. Studies in the last decade have revealed that in addiphase of the cell cycle. One of the molecular mechanisms used by TGF-␤1 to arrest MCs in G1 phase was the tion to soluble regulator molecules, nonsoluble ECM compounds can also influence MC growth. In vitro, significantly diminished activation of cyclin E/cdk2-complexes induced by PDGF. Subsequently, the decrease of freshly seeded MCs do not only plate with much higher efficiency on collagen IV and fibronectin compared with cyclin E/cdk2 activity was reflected by less phosphorylation of the retinoblastoma tumor suppressor (pRb), a plastic, but also show greater replication activity [47] . Thrombospondin-1, an antiadhesive matricellular glyconegative cell cycle regulator [35] . Deactivation of pRb via phosphorylation by G1 phase CDKs is a required protein that promotes cell rounding and division in a variety of cell types, also increases MC proliferation. step for successful G1-phase progression and S-phase entry [40] . Furthermore, in immunoprecipitation experiThis effect might be mediated in part by up-regulation of epidermal growth factor and PDGF secretion, which, ments we found that the presence of TGF-␤1 prevented the release of the CKI p27
Kip1 from cyclin E/cdk2 comin turn, can increase MC proliferation in an autocrine manner [48] . Several investigators observed dose-depenplexes in the presence of soluble mitogens (unpublished results). This appears to be one molecular mechanism dent inhibition of MC proliferation by heparan sulfate [49, 50] . Furthermore, several proteoglycans are able The results of these studies indicate a direct growthpromoting function of integrin-dependent shc signaling to bind and sequester various cytokines, for example, TGF-␤ and bFGF. Local storage of such factors could in anchorage-dependent growth. Recently, caveolin-1 was identified as a membrane adaptor protein that links represent an important regulatory function of glomerular proteoglycans. Morita et al reported that heparan sulfate the integrin ␣ chain to the tyrosine kinase c-fyn, which, in turn, activates and binds shc [59] . Results of our current proteoglycans show an enrichment of bFGF-binding domains in fibrotic lesions of the peritubular interstitium studies have shown that these signaling molecules are also operative and regulated in cultured MCs (unpub- [51] . Taken together, these results support the notion that ECM molecules bind and sequester growth factors, lished observations). However, the precise nuclear signaling events that mediate ECM effects to control quiespossibly providing a local "reservoir" of regulatory proteins and presenting them to adjacent cells in a biologicence or proliferation of MCs remain to be clarified. As an in vitro system to study the effects of structurally maintained in suspension [53] . These data establish a altered ECM molecules, we examined how two structurcell cycle basis to explain the combined requirement of ally distinct forms of type I collagen, monomer versus both growth factors and ECM for anchorage-dependent polymerized fibrils, affect proliferation and expression growth of cells that are in transit through the G1 phase of G1-phase regulators in MCs, using two-dimensional and entry into the S phase.
cell culture. The adhesion of MCs to monomer or polyIn addition to the need of mere cell anchorage for merized collagen was similarly effective. However, in proliferation, the pattern of expressed adhesion molecontrast to control substratum of plastic or monomer cules may also influence cell cycle progression. The excollagen, polymerized collagen completely prevented the pression of integrin ␤1C, an alternatively spliced variant serum-induced increase of DNA synthesis and MC repliof ␤1 integrin, has been described to inhibit growth by cation. The inhibitory effect of polymerized type I collablocking cell cycle progression in the late G1 phase in gen was characterized by the rapid down-regulation of fibroblasts [54] and epithelial cells [55] . Recently, intecyclins D1 and E and the lack of serum-mediated supgrin ␤1C was identified as an upstream regulator of the pression of the CKI p27 Kip1 [63] . We speculate that poly-CKI p27 Kip1 : overexpression of integrin ␤1C was associmerized type I collagen fibrils specifically regulate early ated with induction of p27 Kip1 protein levels, inhibition ␣ 1 ␤ 1 or ␣ 2 ␤ 1 integrin signaling, which leads to inhibition of cyclin A-dependent kinase activity, and increased asof MC proliferation. In cultured MCs, polymerized type sociation of p27
Kip1 with cyclin A [56]. Giancotti et al have I collagen also diminished c-fos induction and the activaexamined mitogenic signaling mechanisms mediated by tion of various kinases involved in intracellular signaling integrin receptors in endothelial cells and fibroblasts and events [64] . This study did not examine whether the could identify pathways specific for subgroups of inte-ECM-driven cellular effects are regulated by integringrins (discussed in F. Giancotti's abstract in this Sympomediated signals. sium issue). Although most integrins are capable of activating focal adhesion kinase upon attachment to ECM, CONCLUSION ␣ 1 ␤ 1 , ␣ 5 ␤ 1 , ␣ v ␤ 3 , and ␣ 6 ␤ 4 integrins are coupled to the rasTaken together, the control of quiescence, prolifera-ERK pathway via recruitment of the adaptor protein shc tion, and survival of MCs greatly affects glomerular [57] [58] [59] . The shc adaptor links various tyrosine kinases structure and function in normal or diseased kidneys. to ras by recruiting the Grb2/SOS complex to the cell Some of the regulatory mechanisms that are operative membrane [60] . In endothelial cells and keratinocytes, in MCs in culture and in vivo have recently been clarified. ligation of integrins linked to shc enabled the progression They involve multiple specific soluble or nonsoluble exthrough the G1 phase in response to soluble mitogens. tracellular factors, and a complex array of receptor-mediIn contrast, ligation of other integrins resulted in growth arrest, even in the presence of soluble mitogens [58, 61] .
ated signals that control cell cycle progression as well as
